Background: Clinical reads of coronary computed tomography angiography (CTA), especially by less experienced readers, may result in overestimation of coronary artery disease stenosis severity compared with expert interpretation. Artificial intelligence (AI)-based solutions applied to coronary CTA may overcome these limitations. Objectives: This study compared the performance for detection and grading of coronary stenoses using artificial intelligence-enabled quantitative coronary computed tomography (AI-QCT) angiography analyses to core lab-interpreted coronary CTA, core lab quantitative coronary angiography (QCA), and invasive fractional flow reserve (FFR). Methods: Coronary CTA, FFR, and QCA data from 303 stable patients (64 ± 10 years of age, 71% male) from the CREDENCE (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia) trial were retrospectively analyzed using an Food and Drug Administration-cleared cloud-based software that performs AI-enabled coronary segmentation, lumen and vessel wall determination, plaque quantification and characterization, and stenosis determination. Results: Disease prevalence was high, with 32.0%, 35.0%, 21.0%, and 13.0% demonstrating ≥50% stenosis in 0, 1, 2, and 3 coronary vessel territories, respectively. Average AI-QCT analysis time was 10.3 ± 2.7 minutes. AI-QCT evaluation demonstrated per-patient sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 94%, 68%, 81%, 90%, and 84%, respectively, for ≥50% stenosis, and of 94%, 82%, 69%, 97%, and 86%, respectively, for detection of ≥70% stenosis. There was high correlation between stenosis detected on AI-QCT evaluation vs QCA on a per-vessel and per-patient basis (intraclass correlation coefficient = 0.73 and 0.73, respectively; P < 0.001 for both). False positive AI-QCT findings were noted in in 62 of 848 (7.3%) vessels (stenosis of ≥70% by AI-QCT and QCA of <70%); however, 41 (66.1%) of these had an FFR of <0.8. Conclusions: A novel AI-based evaluation of coronary CTA enables rapid and accurate identification and exclusion of high-grade stenosis and with close agreement to blinded, core lab-interpreted quantitative coronary angiography. (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia [CREDENCE]; NCT02173275).

AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy / W.F. Griffin, A.D. Choi, J.S. Riess, H. Marques, H. Chang, J.H. Choi, J. Doh, A. Her, B. Koo, C. Nam, H. Park, S. Shin, J. Cole, A. Gimelli, M.A. Khan, B. Lu, Y. Gao, F. Nabi, R. Nakazato, U.J. Schoepf, R.S. Driessen, M.J. Bom, R. Thompson, J.J. Jang, M. Ridner, C. Rowan, E. Avelar, P. Généreux, P. Knaapen, G.A. de Waard, G. Pontone, D. Andreini, J.P. Earls. - In: JACC: CARDIOVASCULAR IMAGING. - ISSN 1876-7591. - 16:2(2023 Feb), pp. 193-205. [10.1016/j.jcmg.2021.10.020]

AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy

G. Pontone;D. Andreini
Penultimo
;
2023

Abstract

Background: Clinical reads of coronary computed tomography angiography (CTA), especially by less experienced readers, may result in overestimation of coronary artery disease stenosis severity compared with expert interpretation. Artificial intelligence (AI)-based solutions applied to coronary CTA may overcome these limitations. Objectives: This study compared the performance for detection and grading of coronary stenoses using artificial intelligence-enabled quantitative coronary computed tomography (AI-QCT) angiography analyses to core lab-interpreted coronary CTA, core lab quantitative coronary angiography (QCA), and invasive fractional flow reserve (FFR). Methods: Coronary CTA, FFR, and QCA data from 303 stable patients (64 ± 10 years of age, 71% male) from the CREDENCE (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia) trial were retrospectively analyzed using an Food and Drug Administration-cleared cloud-based software that performs AI-enabled coronary segmentation, lumen and vessel wall determination, plaque quantification and characterization, and stenosis determination. Results: Disease prevalence was high, with 32.0%, 35.0%, 21.0%, and 13.0% demonstrating ≥50% stenosis in 0, 1, 2, and 3 coronary vessel territories, respectively. Average AI-QCT analysis time was 10.3 ± 2.7 minutes. AI-QCT evaluation demonstrated per-patient sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 94%, 68%, 81%, 90%, and 84%, respectively, for ≥50% stenosis, and of 94%, 82%, 69%, 97%, and 86%, respectively, for detection of ≥70% stenosis. There was high correlation between stenosis detected on AI-QCT evaluation vs QCA on a per-vessel and per-patient basis (intraclass correlation coefficient = 0.73 and 0.73, respectively; P < 0.001 for both). False positive AI-QCT findings were noted in in 62 of 848 (7.3%) vessels (stenosis of ≥70% by AI-QCT and QCA of <70%); however, 41 (66.1%) of these had an FFR of <0.8. Conclusions: A novel AI-based evaluation of coronary CTA enables rapid and accurate identification and exclusion of high-grade stenosis and with close agreement to blinded, core lab-interpreted quantitative coronary angiography. (Computed TomogRaphic Evaluation of Atherosclerotic DEtermiNants of Myocardial IsChEmia [CREDENCE]; NCT02173275).
English
artificial intelligence; atherosclerosis; coronary CTA; coronary artery disease; coronary computed tomography; fractional flow reserve; quantitative coronary angiography
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Articolo
Esperti anonimi
Pubblicazione scientifica
Goal 3: Good health and well-being
feb-2023
Elsevier
16
2
193
205
13
Pubblicato
Periodico con rilevanza internazionale
pubmed
scopus
crossref
datacite
Aderisco
info:eu-repo/semantics/article
AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy / W.F. Griffin, A.D. Choi, J.S. Riess, H. Marques, H. Chang, J.H. Choi, J. Doh, A. Her, B. Koo, C. Nam, H. Park, S. Shin, J. Cole, A. Gimelli, M.A. Khan, B. Lu, Y. Gao, F. Nabi, R. Nakazato, U.J. Schoepf, R.S. Driessen, M.J. Bom, R. Thompson, J.J. Jang, M. Ridner, C. Rowan, E. Avelar, P. Généreux, P. Knaapen, G.A. de Waard, G. Pontone, D. Andreini, J.P. Earls. - In: JACC: CARDIOVASCULAR IMAGING. - ISSN 1876-7591. - 16:2(2023 Feb), pp. 193-205. [10.1016/j.jcmg.2021.10.020]
open
Prodotti della ricerca::01 - Articolo su periodico
33
262
Article (author)
Periodico con Impact Factor
W.F. Griffin, A.D. Choi, J.S. Riess, H. Marques, H. Chang, J.H. Choi, J. Doh, A. Her, B. Koo, C. Nam, H. Park, S. Shin, J. Cole, A. Gimelli, M.A. Khan...espandi
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1936878X22000018-main.pdf

accesso aperto

Descrizione: Original Research
Tipologia: Publisher's version/PDF
Dimensione 2.66 MB
Formato Adobe PDF
2.66 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/954866
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 177
  • ???jsp.display-item.citation.isi??? 140
  • OpenAlex 186
social impact